Cargando…

THE INDUCTION OF GRAFT VERSUS HOST DISEASE IN MICE TREATED WITH CYCLOPHOSPHAMIDE

In these studies adult mice treated with cyclophosphamide and foreign immunologically competent cells developed a graft versus host disease which outwardly resembled that encountered in other experimental systems. Progressively larger doses of cyclophosphamide produced an increasingly severe disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owens, Albert H., Santos, George W.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1968
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138517/ https://www.ncbi.nlm.nih.gov/pubmed/4873022

Ejemplares similares

Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
por: Fante, Matthias A., et al.
Publicado: (2020)

Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
por: Nunes, Natalia S., et al.
Publicado: (2019)

Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
por: Ardizzoia, Federica, et al.
Publicado: (2022)

Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models
por: Mashima, Kiyomi, et al.
Publicado: (2021)

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial
por: Broers, Annoek E. C., et al.
Publicado: (2022)

Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells
por: Ritacco, Caroline, et al.
Publicado: (2023)

Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease
por: Gilman, Kristy E., et al.
Publicado: (2023)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Fluoxetine Reduces Murine Graft-Versus-Host Disease by Induction of T cell Immunosuppression
por: Gobin, Veerle, et al.
Publicado: (2013)

Sequential morphology of graft-versus-host disease in the rat radiation chimera()
por: Beschorner, William E., et al.
Publicado: (1982)

Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
por: Nagler, Arnon, et al.
Publicado: (2020)

Requirements for the induction and adoptive transfer of cyclosporine- induced syngeneic graft-versus-host disease
Publicado: (1989)

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
por: Hamadani, Mehdi, et al.
Publicado: (2020)

RAPID VIRAL INDUCTION OF MURINE LYMPHOMAS IN THE GRAFT-VERSUS-HOST REACTION
por: Cornelius, Eugene A.
Publicado: (1972)

Ovarian protection in cyclophosphamide-treated mice by fennel
por: Hassanpour, Azam, et al.
Publicado: (2017)

P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
por: Shimoni, A., et al.
Publicado: (2022)

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
por: Lazzari, Lorenzo, et al.
Publicado: (2022)

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated
por: Nikiforow, Sarah, et al.
Publicado: (2018)

Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
por: Kunacheewa, Chutima, et al.
Publicado: (2020)

Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching
por: Irene, García-Cadenas, et al.
Publicado: (2020)

Corneal perforation in ocular graft-versus-host disease
por: Zhang, Cathy Y., et al.
Publicado: (2021)

Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease
por: Santos e Sousa, Pedro, et al.
Publicado: (2018)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice
por: Kosugi-Kanaya, Mizuha, et al.
Publicado: (2017)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
por: Wang, Long, et al.
Publicado: (2013)

Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice
por: Mukai, Shin, et al.
Publicado: (2018)

Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice
por: Rezende, Barbara Maximino, et al.
Publicado: (2019)

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
por: Abudayyeh, Ala, et al.
Publicado: (2015)

Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice
por: Mukai, Shin, et al.
Publicado: (2018)

Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice
por: Khuat, Lam T., et al.
Publicado: (2021)

Transfusion-associated graft-versus-host disease.
por: Rappeport, J. M.
Publicado: (1990)

Update on ocular graft-versus-host disease
por: Nair, Sridevi, et al.
Publicado: (2021)

T cell metabolism in graft-versus-host disease
por: Zou, Yujing, et al.
Publicado: (2020)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation
por: Wada, Fumiya, et al.
Publicado: (2023)

Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells
por: van der Wall, E, et al.
Publicado: (2000)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
por: Mohamed, Fathima A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rd5j7tlfn90qfqubvop0d70ovc